Skip to main content
. 2022 Jan 29;2022:3969542. doi: 10.1155/2022/3969542

Table 2.

Patients with giant parathyroid adenoma, clinical characteristics, tumor pathologies and postoperative complications.

Case report Gender Age (Years) Side Presentation Ca (mg/dL)/PTH (ng/L) Dimensions (mm) Weight (g) Pathology Post-operative complications
Aggarwal et al., 2009 [22] F 33 L Edema, palpable nodule, bone pain, R humerus and R pelvic fracture 10.6/762 95 × 50 × 35 102 Chief cell adenoma Symptomatic hypocalcemia

Salehian et al., 2009 [23] F 53 R Edema, bone pain, weight loss, nausea, vomit 14.63/1624 55 × 35 × 20 30 PTA No complication

Sisodiya et al., 2011 [24] F 52 R Recurrent vomit 17.03/598 39 × 20 × 17 ND ND Hypocalcemia

Asghar et al., 2012 [25] F 55 L Parathyroid crisis, palpable nodule 23.05/1182 110 × 70 × 60 ND Cystic degeneration PTA, no lymph node metastasis No complication

Vilallonga et al., 2012 [26] F 19 L Parathyroid crisis 14.23/1207 Maximum diameter 30 70 Intrathyroid PTA No complication

Neagoe et al., 2014 [27] M/F/F 57/60/33 R/L/R C 1: bone pain, abdominal pain, nausea, palpable nodule. C 2: parathyroid crisis, palpable nodule. C 3: recurrent renal calculi, brown tumor in tibia C 1 : 3.54/1780 C 2 : 16.19/863 C 3 : 12.63/1174 C 1 : 50 × 30 × 20 C 2 : 55 × 40 × 30 C3ND C 1 : 30.6 C 2 : 35.2 C 3:>30 2 PTA; 1 partially cystic PTA C 1: hungry bone syndrome C 2: mild hypocalcemia and hungry bone syndrome C 3: mild hypocalcemia

Haldar et al., 2014 [28] F 61 L Asymptomatic 12.71/179.2 65 × 30 × 15 12 PTA No complication

Garas et al., 2015 [29] F 53 L Palpable nodule, bone pain 15.95/4038 Maximum diameter 70 27 Chief cell PTA No complication

Case report Gender Age (Years) Side Presentation Ca (mg/dL)/PTH (ng/L) Dimensions (mm) Weight (g) Pathology Post-operative complications

Rutledge et al., 2016 [30] F 21 R Neck mass enlargement, constipation, palpable nodule 10.94/1305.1 80 × 55 × 30 58.8 Atypical PTA Symptomatic hypocalcemia, hungry bone syndrome

Krishnamurthy et al., 2016 [31] M 50 L Recurrent acute pancreatitis crisis, palpable neck mass 11.1/669 Maximum diameter 60 20 PTA Hipocalcemia

Castro et al., 2017 [32] F 40 L Asymptomatic palpable nodule 13.43/825 64 × 16 × 20 10.8 PTA Hypocalcemia

Sahsamanis et al., 2017 [33] F 42 L Abdominal pain 10.42/151 33 × 20 × 14 5.39 PTA No complication

Mantzoros et al., 2018 [34] F 73 R Enlargement of neck size, bone pain 14.55/1629 50 × 25 × 25 30 PTA Hungry bone syndrome

Migliore et al., 2013 [35] F 65 R Persistent hypercalcemia Both elevated ― 95 PTA No complication

Taghavi Kojidi et al., 2016 [36] M 70 Middle Anorexia, nausea, bone pain, constipation, symptomatic nephrolithiasis, polydipsia 14.55/930 ― 75 Active parathyroid lesion Hypocalcemia

Pecheva et al., 2016 [37] F 72 R Depression, severeosteoporosis (T = − 3,2) 12.1/250.8 ― 19 PTA Hoarseness, cough

Talukder et al., 2017 [38] F 49 Middle Brown tumor 14.07/1000 40 × 30 × 20 12 Neuroendocrine cell tumor No complication

Garuna Murthee et al., 2018 [39] M 72 Middle Anorexia, lethargy, abdominal cramps, constipation, weight loss 15.19/1867.1 Maximum diameter 78 220 Intrathymic PTA No complication

Miller et al., 2019 [40] M 53 Middle Asymptomatic nephrolithiasis 11.22/179.2 80 × 30 × 30 30.9 PTA No complication

P liu et al., 2020 [41] M 79 L/R Obstructive right nephropathy, and acute kidney injury secondary to hypercalcemia 13.19/420.5 L: 50 × 25 × 12 R: 48 × 22 x 10 L:8101 R:7339 PTA No complication

Giuseppe Evola et al., 2020 [42] F 52   Musculoskeletal pain, constipation, polyuria, pathological fracture of bilateral femur 12.5/27.47 65 × 50 x 30 90 PTA No complication

Alvarez JC et al., 2021 [our case] F 55 R Polyarthralgias, pathological fracture of humerus, brown tumor of humerus 14.9/1973 Maximum diameter 5 16 PTA Hungry bone syndrome